Question

In: Accounting

Canberra acquired all of the equity shares in Yass on 1 October 2019, for consideration of...

Canberra acquired all of the equity shares in Yass on 1 October 2019, for consideration of $2,150 million. The carrying amount of identifiable net assets at acquisition was $2,130 million, which was the same as the fair value. Canberra is actively selling its entire shareholding in Yass as a single transaction and has classified the investment as a disposal group held for sale, in accordance with IFRS 5 Non-current Assets Held for Sale and Discontinued Operations, for the year ended 30 September 2020. The carrying amounts of the net assets of Yass in the individual financial statements of Canberra at 30 September 2020, before classification as held for sale, were ($ million):

Canberra measures properties at fair value, in accordance with IAS 16 Property, Plant and Equipment. No revaluations had been recognised on acquisition, when the estimated fair values were substantially the same as the carrying amounts. Properties with a carrying amount of $630 million were revalued to fair value of $680 million, at 30 September 2020. This fair value change has not been recognised in the financial statements. The total fair value less costs to sell of the disposal group was estimated as $2,140 million, at 30 September 2020. No impairments had been recognised previously, to the goodwill of Yass.

Yass owns and operates private hospitals and the medical sector is highly regulated. Canberra is confident that the sale of Yass will be agreed shortly after 30 September 2020. Any purchaser will require regulatory approval, which could delay completion of the sale until after 30 September 2021. Regulatory approval cannot be sought by a purchaser until a contract of sale had been agreed. Yass will continue to operate the hospitals until the sale is completed. Canberra will sell all of the shares in Yass to the purchaser, who would obtain all of Yass’s rights and obligations. Yass does not intend to sell or acquire any significant assets or liabilities prior to completion of the sale, as that would affect the value of the shares being sold.

Required:

Discuss the correct recognition and measurement of the investment in Yass in the consolidated financial statements, for the year ended 30 September 2020. Provide calculations.     

Solutions

Expert Solution


Related Solutions

Canberra acquired all of the equity shares in Yass on 1 October 2019, for consideration of...
Canberra acquired all of the equity shares in Yass on 1 October 2019, for consideration of $2,150 million. The carrying amount of identifiable net assets at acquisition was $2,130 million, which was the same as the fair value. Canberra is actively selling its entire shareholding in Yass as a single transaction and has classified the investment as a disposal group held for sale, in accordance with IFRS 5 Non-current Assets Held for Sale and Discontinued Operations, for the year ended...
Carina Ltd has acquired all the shares of Finn Ltd on 1 July 2019 for $...
Carina Ltd has acquired all the shares of Finn Ltd on 1 July 2019 for $ 225 000. The accountant for Carina Ltd, having studied the requirements of AASB 3 Business Combinations, realises that all the identifiable assets and liabilities of Finn Ltd must be recognised in the consolidated financial statements at fair value. Although he is happy about the valuation of these items, he is unsure of a number of other matters including pre-acquisition entries and business combination valuation...
On 1 July 2019, Gail Ltd acquired all the issued shares of Ray Ltd for $90...
On 1 July 2019, Gail Ltd acquired all the issued shares of Ray Ltd for $90 000. The financial statements of Ray Ltd showed the equity of Ray Ltd at that date to be: Share capital-10000 $5 50,000 General reserve 25000 Retained earning 15000 All the assets and liabilities of Ray Ltd were recorded at amounts equal to their fair values at that date. During the year ending 30 June 2020, Ray Ltd undertook the following actions. • On 1...
On 1 July 2019, Batman Ltd acquired all the issued shares (cum div.) of Robin Ltd...
On 1 July 2019, Batman Ltd acquired all the issued shares (cum div.) of Robin Ltd for $150 000. At this date the equity of Robin Ltd consisted of: Share capital $75 000 Retained earnings $22 500 At this date, Robin Ltd had recorded a dividend payable of $22 500 which was paid in August 2019. All the identifiable assets and liabilities of Robin Ltd were recorded at amounts equal to fair values except for inventory for which the fair...
Blue Ltd acquired on 1 July 2019 all the issued shares (cum div.) of ‘Pink’ Ltd...
Blue Ltd acquired on 1 July 2019 all the issued shares (cum div.) of ‘Pink’ Ltd for $33 000. At this date, the equity of ‘Pink’ Ltd was as follows. Share Capital $ 20 000 General Reserve 2 000 Retained Earnings 5 000 All the identifiable assets and liabilities of ‘Pink’ Ltd were recorded at amounts equal to their fair values except for the following. Carrying Amount Fair Value Plant Cost ($22 000) $18 000 $18 600 Land 19 000...
On 1 January 2019, Melor acquired 90% of the equity share capital of Chempaka in a share exchange in which Melor issued two new shares for every three shares it acquired in Chempaka.
On 1 January 2019, Melor acquired 90% of the equity share capital of Chempaka in a shareexchange in which Melor issued two new shares for every three shares it acquiredin Chempaka. Additionally, on 31 December 2019, Melor will pay the shareholders ofChempaka RM1.76 per share acquired. Melor’s cost of capital is 10% per annum. At the dateof acquisition, shares in Melor and Chempaka had a share market value of RM6.50 andRM2.50 each respectively.Statement of Profit of Loss for the year...
On 1 July 2019 Short Ltd acquired 80% of the shares of Tall Ltd for $436...
On 1 July 2019 Short Ltd acquired 80% of the shares of Tall Ltd for $436 200. At this date the equity of Tall Ltd consisted of share capital of $280 000 and retained earnings of $140 000. All the identifiable asset and liabilities of Tall Ltd were recorded at amounts equal to fair value except for: Carrying amount FV Land 80 000 95 000 Plant (Cost $380 000) 300 000 330 000 Inventories 15 000 18 000 The plant...
Entity A invested in 20,000 shares of a listed company in October 2019 at a cost...
Entity A invested in 20,000 shares of a listed company in October 2019 at a cost of $3.80 per share. On 31 December 2019, the shares have a market value of $3.40. Entity A is not planning on selling these shares in the short term and elects to hold them as Fair Value through Other Comprehensive Income. REQUIRED: (1) Measure the amounts of the equity investment recognised in the Statement of Financial Position for the year-end of 2019. (2) Measure...
Salidou Ltd acquired all the shares of Chocolat Ltd on 1 July 2018. All the net...
Salidou Ltd acquired all the shares of Chocolat Ltd on 1 July 2018. All the net assets of Chocolat Ltd were at fair value at the date of acquisition except for an equipment, which was below its fair value. The remaining useful life of the equipment is 5 years. At 30 June 2023, depreciation expense will need to be debited. True False
On 1 January 2019 Liam Ltd acquired 90% of the issued shares of Ian Ltd. During...
On 1 January 2019 Liam Ltd acquired 90% of the issued shares of Ian Ltd. During the year ended 31 December 2019 the following intra group transactions occurred: Sales of inventory: Ian Ltd sold inventory to Liam Ltd $360,000. This inventory costed Ian Ltd $300,000. At 31 December 2019 Liam Ltd held 50% of the inventory acquired from Ian Ltd. Intragroup sale of equipment: An item of equipment originally acquired by Liam Ltd on 1 January 2017 at a cost...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT